A comprehensive survey into the role of microRNAs in ovarian cancer chemoresistance; an updated overview.

J Ovarian Res · 2022 · PMC9264529 · PMID 35799305

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

moderately significantno p-value reported

While the trial found that adding bevacizumab to single-agent chemotherapy resulted in considerably prolonged PFS and ORR, the results also revealed moderately significant drug-related toxicity [ 37 ].

also in 2,178 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.